AHA Files Formal Opposition to HRSA 340B Rebate Model — FQHC/Hospital Alignment on 'Flawed Mechanism'
The American Hospital Association filed formal opposition to HRSA's 340B rebate model RFI on April 20, 2026 — the comment deadline — framing 'any rebate mechanism is flawed' and warning the shift will cost billions and jeopardize access for millions. AHA joins NACHC and PhRMA in opposing the rebate pilot.
The unified FQHC/hospital front strengthens the 340B defense as manufacturer rebate plans continue activating (Lilly, Novo already live; 9th plan effective April 1).
Linked evidence
American Hospital AssociationSource packet
This story's linked evidence + 4 related tracked stories with theirs — one print-ready digest for your team or board packet.
Free — unlocks the packet and submits a single opt-in for Intel Brief. Eligible addresses are subscribed immediately and no confirmation email is sent; a prior unsubscribe, verified deletion, or bounce is not overridden. Individual sources are always clickable above, no email needed.
FQHC Talent. (2026, April 20). AHA Files Formal Opposition to HRSA 340B Rebate Model — FQHC/Hospital Alignment on 'Flawed Mechanism'. Linked evidence: American Hospital Association. Retrieved September 11, 2026, from https://www.fqhctalent.com/intel/aha-hrsa-340b-rebate-opposition-april-20-2026
More in Lobbying & Advocacy
Jul 24
NACHC backs a bipartisan House letter asking CMS to set telehealth payment parity for health centers and rural clinics
Jul 8
CMS Keeps the 35% Essential Community Provider Standard in the 2027 Marketplace Final Rule — a Rulemaking Win NACHC Fought For
Jun 25
California's Health-Ballot Deal Withdraws the Executive-Pay Cap and Union-Spending Countermeasure; Proposition 44 Remains
May 22
California Hospital Association Warns FQHC Closures Will Drive Up ED Visits — First Time Hospital Lobby Publicly Backs FQHC Sustainability